| Year |
Citation |
Score |
| 2020 |
Bradbury AR, Egleston BL, Patrick-Miller LJ, Rustgi N, Brandt A, Brower J, DiGiovanni L, Fetzer D, Berkelbach C, Long JM, Powers J, Stopfer JE, Domchek SM. Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patients. Clinical Genetics. PMID 32022897 DOI: 10.1111/Cge.13716 |
0.36 |
|
| 2020 |
Liu JC, Egleston B, Blackman E, Ragin C. Abstract 1175: Race informs survival disparities in head and neck cancer clinical trials Epidemiology. 80: 1175-1175. DOI: 10.1158/1538-7445.Am2020-1175 |
0.357 |
|
| 2020 |
Bauman J, Panick J, Galloway T, Ridge J, McShane M, Chwistek M, Collins M, Kinczewski L, Murphy K, Welsh M, Farren M, Clark M, Kelly J, Schuster K, Stokes L, ... ... Egleston B, et al. A Pilot Study of a Comprehensive Palliative Care Intervention to Improve Symptoms and Coping During Curative-Intent Chemoradiation in Patients with Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 106: 1208. DOI: 10.1016/J.Ijrobp.2019.11.070 |
0.309 |
|
| 2019 |
Jones EA, Shuman AG, Egleston BL, Liu JC. Common Pitfalls of Head and Neck Research Using Cancer Registries. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 194599819838823. PMID 30939098 DOI: 10.1177/0194599819838823 |
0.329 |
|
| 2019 |
Bauman JR, Panick J, Galloway TJ, Ridge JA, McShane M, Chwistek M, Collins M, Kinczewski L, Murphy K, Welsh M, Farren M, Clark M, Kelly J, Schuster K, Stokes L, ... ... Egleston BL, et al. Feasibility of a collaborative palliative and oncology care intervention to improve symptoms and coping during head and neck chemoradiation. Journal of Clinical Oncology. 37: 73-73. DOI: 10.1200/Jco.2019.37.31_Suppl.73 |
0.312 |
|
| 2019 |
Zhang E, Deng M, Egleston B, Wong J, Su S, Denlinger C, Meyer J. Dose to Heart, Spine, Aorta, and Body Predict for Severe Lymphopenia and Poor Survival in Patients Undergoing Chemoradiation for Esophageal Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E206-E207. DOI: 10.1016/J.Ijrobp.2019.06.2041 |
0.31 |
|
| 2019 |
Burbure N, Egleston B, Paly J, Lee D, Kutikov A, Hayes S, Sobczak M, Horwitz E, Hallman M. Long-Term Quality of Life Outcomes for High Risk Prostate Cancer Patients after Primary Treatment with Surgery Vs Radiation + ADT International Journal of Radiation Oncology*Biology*Physics. 105: E267. DOI: 10.1016/J.Ijrobp.2019.06.1881 |
0.307 |
|
| 2018 |
Beri N, Patrick-Miller LJ, Egleston BL, Hall MJ, Domchek SM, Daly MB, Ganschow P, Grana G, Olopade OI, Fetzer D, Brandt A, Chambers R, Clark DF, Forman A, Gaber R, et al. Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multi-center COGENT Study. Clinical Genetics. PMID 30417332 DOI: 10.1111/Cge.13474 |
0.327 |
|
| 2018 |
Frost CJ, Andrulis IL, Buys SS, Hopper JL, John EM, Terry MB, Bradbury A, Chung WK, Colbath K, Quintana N, Gamarra E, Egleston B, Galpern N, Bealin L, Glendon G, et al. Assessing patient readiness for personalized genomic medicine. Journal of Community Genetics. PMID 29804257 DOI: 10.1007/S12687-018-0365-5 |
0.31 |
|
| 2018 |
Bradbury AR, Patrick-Miller LJ, Egleston BL, Hall MJ, Domchek SM, Daly MB, Ganschow P, Grana G, Olopade OI, Fetzer D, Brandt A, Chambers R, Clark DF, Forman A, Gaber R, et al. Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results. Journal of the National Cancer Institute. PMID 29490071 DOI: 10.1093/Jnci/Djy015 |
0.307 |
|
| 2018 |
Bagnyukova T, Egleston B, Kramer M, Astsaturov I, Golemis E, Borghaei H. Abstract 3469: Dual inhibition of the EGFR and Aurora A pathways in Kras mutated non-small cell lung cancers Cancer Research. 78: 3469-3469. DOI: 10.1158/1538-7445.Am2018-3469 |
0.314 |
|
| 2018 |
Boumber Y, Aggarwal C, Thrash-Bingham C, Fittipaldi P, Guseva P, Vlasenkova R, Rao C, Pei J, Egleston BL, Borghaei H, Cristofanilli M, Mehra R, Serebriiskii I, Alpaugh RK. Abstract 1584: Comparison of circulating tumor cell (CTC) capture/identification methods and NanoString evaluation of gene expression in CTCs and cell-free circulating tumor mRNA (cctmRNA) in patients with metastatic lung cancer Cancer Research. 78: 1584-1584. DOI: 10.1158/1538-7445.Am2018-1584 |
0.331 |
|
| 2018 |
Leachman BK, DeMora L, Churilla TM, Ebersole B, Bauman J, Ridge JA, Lango M, Egleston B, Galloway TJ. Multidisciplinary Care of Head and Neck Cancer in Elderly Patients International Journal of Radiation Oncology Biology Physics. 100: 1329. DOI: 10.1016/J.Ijrobp.2017.12.061 |
0.324 |
|
| 2017 |
Meeker CR, Wong YN, Egleston BL, Hall MJ, Plimack ER, Martin LP, von Mehren M, Lewis BR, Geynisman DM. Distress and Financial Distress in Adults With Cancer: An Age-Based Analysis. Journal of the National Comprehensive Cancer Network : Jnccn. 15: 1224-1233. PMID 28982748 DOI: 10.6004/Jnccn.2017.0161 |
0.322 |
|
| 2017 |
Egleston BL, Uzzo RG, Wong YN. Latent Class Survival Models Linked by Principal Stratification to Investigate Heterogenous Survival Subgroups Among Individuals With Early-Stage Kidney Cancer. Journal of the American Statistical Association. 112: 534-546. PMID 28966417 DOI: 10.1080/01621459.2016.1240078 |
0.328 |
|
| 2017 |
Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, Brinton LA, Egleston BL, Falk RT, Fortner RT, Helzlsouer KJ, Gao Y, Idahl A, Kaaks R, Krogh V, Merritt MA, et al. Anti-Müllerian Hormone and risk of ovarian cancer in nine cohorts. International Journal of Cancer. PMID 28921520 DOI: 10.1002/Ijc.31058 |
0.324 |
|
| 2017 |
Denlinger CS, Hall MJ, Cohen SJ, Astsaturov IA, Dotan E, Engstrom PF, Egleston BL, Fang CY. Physical activity intervention for patients with advanced pancreatic cancer. Journal of Clinical Oncology. 35: 217-217. DOI: 10.1200/Jco.2017.35.5_Suppl.217 |
0.315 |
|
| 2017 |
Liu Y, Ramamurthy C, Anari F, Varshavsky A, Martin J, Kasireddy V, Goldrich A, Ghatalia P, Gerson J, Smith C, Knollman HM, Tan C, Egleston BL, Collins M, Dotan E, et al. End-of-life (EOL) care in medical oncology fellows' clinics. Journal of Clinical Oncology. 35: 75-75. DOI: 10.1200/Jco.2017.35.31_Suppl.75 |
0.316 |
|
| 2017 |
Avkshtol V, Arora S, Lesh R, Golemis E, Egleston B, Meyer J. Peripheral Blood Lymphocyte Gamma-H2AX as a Predictor for Treatment Response in Rectal Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 99: E576-E577. DOI: 10.1016/J.Ijrobp.2017.06.1988 |
0.303 |
|
| 2017 |
Leachman BK, DeMora L, Churilla TM, Bauman J, Lango M, Egleston B, Galloway TJ. Patterns of Initial Therapy for Larynx Cancer in Elderly Patients: A Population Based Analysis International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1569 |
0.312 |
|
| 2016 |
Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, Md JM. Causes of death among cancer patients. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 27831506 DOI: 10.1093/Annonc/Mdw604 |
0.331 |
|
| 2016 |
Churilla TM, Egleston B, Bleicher R, Dong Y, Meyer J, Anderson P. Disparities in the Local Management of Breast Cancer in the US according to Health Insurance Status. The Breast Journal. PMID 27797159 DOI: 10.1111/Tbj.12705 |
0.362 |
|
| 2016 |
Churilla TM, Egleston BL, Murphy CT, Sigurdson ER, Hayes SB, Goldstein LJ, Bleicher RJ. Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient. Breast Cancer Research and Treatment. PMID 27640196 DOI: 10.1007/S10549-016-3982-X |
0.304 |
|
| 2016 |
Bradbury AR, Patrick-Miller L, Schwartz LA, Egleston BL, Henry-Moss D, Domchek SM, Daly MB, Tuchman L, Moore C, Rauch PK, Shorter R, Karpink K, Sands CB. Psychosocial Adjustment and Perceived Risk Among Adolescent Girls From Families With BRCA1/2 or Breast Cancer History. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27551110 DOI: 10.1200/Jco.2015.66.3450 |
0.304 |
|
| 2016 |
Meeker CR, Geynisman DM, Egleston BL, Hall MJ, Mechanic KY, Bilusic M, Plimack ER, Martin LP, von Mehren M, Lewis B, Wong YN. Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer. Journal of Oncology Practice / American Society of Clinical Oncology. PMID 27328795 DOI: 10.1200/Jop.2016.011049 |
0.303 |
|
| 2016 |
Gaponova AV, Nikonova A, Deneka AY, Kopp MC, Kudinov AE, Skobeleva N, Khazak V, Shin Ogawa L, Cai KQ, Duncan KE, Duncan JS, Egleston BL, Proia DA, Boumber Y, Golemis EA. A novel HSP90 inhibitor-drug conjugate to SN38 is highly effective in small cell lung cancer (SCLC). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27267850 DOI: 10.1158/1078-0432.Ccr-15-3068 |
0.314 |
|
| 2016 |
Churilla T, Egleston B, Dong Y, Shaikh T, Murphy C, Mantia-Smaldone G, Chu C, Rubin S, Anderson P. Disparities in the Management and Outcome of Cervical Cancer in the United States According to Health Insurance Status. Gynecologic Oncology. PMID 27012428 DOI: 10.1016/J.Ygyno.2016.03.025 |
0.32 |
|
| 2016 |
Bradbury AR, Patrick-Miller LJ, Egleston BL, Olopade OI, Hall MJ, Daly MB, Fleisher L, Grana G, Ganschow P, Fetzer D, Domchek SM. Patient-reported outcomes in a multicenter randomized study of in-person versus telephone disclosure of genetic test results for cancer susceptibility. Journal of Clinical Oncology. 34: 1502-1502. DOI: 10.1200/Jco.2016.34.15_Suppl.1502 |
0.329 |
|
| 2016 |
Churilla T, Egleston B, Murphy C, Sigurdson E, Hayes S, Goldstein L, Bleicher R. Abstract P1-07-25: Patterns of multidisciplinary care in the management of nonmetastatic invasive breast cancer in the United States Medicare patient Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P1-07-25 |
0.381 |
|
| 2016 |
Zaorsky NG, Churilla T, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, Meyer JE. Causes of death among cancer patients as a function of calendar year, age, and time after diagnosis Annals of Oncology. 27. DOI: 10.1093/Annonc/Mdw387.10 |
0.311 |
|
| 2016 |
Churilla TM, Egleston B, Dong Y, Lango M, Galloway TJ. The Impact of Health Insurance Status on the Presentation, Local Management, and Outcomes of Patients With Head and Neck Cancer in the United States International Journal of Radiation Oncology Biology Physics. 94: 870. DOI: 10.1016/J.Ijrobp.2015.12.383 |
0.305 |
|
| 2015 |
Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for localized pancreatic cancer. Practical Radiation Oncology. PMID 27032572 DOI: 10.1016/J.Prro.2015.11.005 |
0.329 |
|
| 2015 |
Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, Egleston BL. Time to Surgery and Breast Cancer Survival in the United States. Jama Oncology. 1-10. PMID 26659430 DOI: 10.1001/Jamaoncol.2015.4508 |
0.37 |
|
| 2015 |
Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26628469 DOI: 10.1200/Jco.2015.61.5906 |
0.304 |
|
| 2015 |
Nikonova AS, Deneka AY, Eckman L, Kopp MC, Hensley HH, Egleston BL, Golemis EA. Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease. Frontiers in Oncology. 5: 228. PMID 26528438 DOI: 10.3389/Fonc.2015.00228 |
0.314 |
|
| 2015 |
Bradbury AR, Patrick-Miller L, Schwartz L, Egleston B, Sands CB, Chung WK, Glendon G, McDonald JA, Moore C, Rauch P, Tuchman L, Andrulis IL, Buys SS, Frost CJ, Keegan TH, et al. Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer. Pediatrics. PMID 26482668 DOI: 10.1542/Peds.2015-0498 |
0.315 |
|
| 2015 |
Bleicher RJ, Ruth K, Sigurdson ER, Daly JM, Boraas M, Anderson PR, Egleston BL. Breast conservation versus mastectomy for patients with T3 primary tumors (>5 cm) a review of 5685 medicare patients. Cancer. PMID 26479066 DOI: 10.1002/Cncr.29726 |
0.323 |
|
| 2015 |
Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. American Journal of Clinical Oncology. PMID 26325492 DOI: 10.1097/Coc.0000000000000227 |
0.309 |
|
| 2015 |
Bradbury AR, Patrick-Miller LJ, Egleston BL, DiGiovanni L, Brower J, Harris D, Stevens EM, Maxwell KN, Kulkarni A, Chavez T, Brandt A, Long JM, Powers J, Stopfer JE, Nathanson KL, et al. Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 25834950 DOI: 10.1038/Gim.2015.19 |
0.347 |
|
| 2015 |
Shaikh T, Burki M, Wang LS, Egleston B, Hoffman JP, Cohen SJ, Meyer JE. Identifying factors impacting subsequent gemcitabine dose intensity in patients undergoing chemoradiation for locally advanced pancreatic cancer. Journal of Clinical Oncology. 33: 455-455. DOI: 10.1200/Jco.2015.33.3_Suppl.455 |
0.334 |
|
| 2015 |
Boumber Y, Gaponova A, Nikonova AS, Deneka A, Kudinov A, Egleston BL, Duncan JS, Duncan K, Borghaei H, Mehra R, Proia DA, Golemis E. Preclinical efficacy of STA-12-8666, an HSP90 inhibitor-targeted SN-38 conjugate, in small cell lung cancer (SCLC). Journal of Clinical Oncology. 33: e18560-e18560. DOI: 10.1200/Jco.2015.33.15_Suppl.E18560 |
0.326 |
|
| 2015 |
Bradbury AR, Patrick-Miller LJ, Egleston BL, Maxwell KN, Brandt A, Brower J, Digiovanni L, Long JM, Powers J, Stopfer J, Nathanson KL, Domchek SM. Interest in and outcomes with return of individual genetic research results for inherited susceptibility to breast cancer. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E12503 |
0.319 |
|
| 2015 |
Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross EA, Wong Y, Patel SA, Boraas M, Chang EI, Topham NS, Egleston BL. Time to treatment (TTT) and breast cancer survival in the United States. Journal of Clinical Oncology. 33: 6575-6575. DOI: 10.1200/Jco.2015.33.15_Suppl.6575 |
0.368 |
|
| 2015 |
Bradbury AR, Patrick-Miller L, Egleston B, Schwartz L, Sands CB, Chung W, Glendon G, Tuchman L, Moore C, Rauch P, Andrulis I, Buys S, Frost CJ, John EM, Keegan T, et al. Abstract P6-10-17: Psychosocial adjustment, cancer worry and perceived risk in 6-13 year old girls from breast cancer families Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-10-17 |
0.319 |
|
| 2015 |
Bradbury AR, Patrick-Miller L, Egleston BL, Brandt A, Long J, Powers J, Stopfer J, DiGiovanni L, Brower J, Domchek SM. Abstract P4-12-10: Uptake and outcomes of multiplex testing for breast cancer susceptibility Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-12-10 |
0.345 |
|
| 2015 |
Patrick-Miller L, Harris D, Stevens E, Egleston B, Fleisher L, Mueller R, Brandt A, Stopfer J, Domchek S, Bradbury A. Abstract P1-11-02: Telemedicine: Expanding access to cancer genetic services to underserved populations Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P1-11-02 |
0.316 |
|
| 2015 |
Gaponova A, Nikonova A, Deneka A, Egleston B, Litwin S, Duncan J, Duncan K, Borghaei H, Mehra R, Proia D, Boumber Y, Golemis E. Abstract 1731: Preclinical testing demonstrates strong activity of STA-12-8666, an HSP90 inhibitor-SN-38 conjugate, in small cell lung cancer (SCLC) Cancer Research. 75: 1731-1731. DOI: 10.1158/1538-7445.Am2015-1731 |
0.327 |
|
| 2015 |
Churilla TM, Egleston B, Dong Y, Murphy CT, Anderson PR. Disparities in Clinical Presentation, Management, and Outcomes With Invasive Cervical Cancer According to Insurance Status in the United States International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1446 |
0.3 |
|
| 2014 |
Patrick-Miller LJ, Egleston BL, Fetzer D, Forman A, Bealin L, Rybak C, Peterson C, Corbman M, Albarracin J, Stevens E, Daly MB, Bradbury AR. Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition. Jmir Research Protocols. 3: e49. PMID 25355401 DOI: 10.2196/Resprot.3337 |
0.309 |
|
| 2014 |
Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, Mehra R, Ebersole B, Moran K, Ridge JA. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer Cancer. 120: 840-847. PMID 24352973 DOI: 10.1002/Cncr.28482 |
0.352 |
|
| 2014 |
Smaldone MC, Egleston B, Kim S, Handorf E, Geynisman DM, Wong Y, Uzzo RG, Kutikov A. Does nonsurgical management for localized kidney cancer equate to active surveillance in the SEER-Medicare population? Journal of Clinical Oncology. 32: 444-444. DOI: 10.1200/Jco.2014.32.4_Suppl.444 |
0.369 |
|
| 2014 |
Smaldone MC, Egleston B, Hollingsworth JM, Hollenbeck BK, Miller DC, Kim S, Handorf E, Wong Y, Uzzo RG, Kutikov A. Understanding treatment disconnect and mortality trends in renal cell carcinoma using tumor registry data. Journal of Clinical Oncology. 32: 403-403. DOI: 10.1200/Jco.2014.32.4_Suppl.403 |
0.332 |
|
| 2014 |
Bradbury AR, Patrick-Miller L, Egleston B, Schwartz L, Tuchman L, Moore C, Rauch P, Sands CB, Henry-Moss D, Sicilia P, Karpink K, Domchek SM, Daly MB. Cancer worry, anxiety, and behaviors in girls at familial or genetic risk for breast cancer. Journal of Clinical Oncology. 32: 9527-9527. DOI: 10.1200/Jco.2014.32.15_Suppl.9527 |
0.312 |
|
| 2014 |
Wong Y, Hall MJ, Mechanic K, Geynisman DM, Meeker C, Bilusic M, Plimack ER, Mehren Mv, Martin LP, Kreamer KM, Egleston B. Relationships among financial distress, emotional symptoms, and overall distress in insured cancer patients. Journal of Clinical Oncology. 32: 6540-6540. DOI: 10.1200/Jco.2014.32.15_Suppl.6540 |
0.307 |
|
| 2014 |
Bagnyukova T, Pan X, Zhang J, Egleston B, Astsaturov I, Golemis E, Borghaei H. Abstract 4242: Effects of dual inhibition of EGFR and Aurora A kinase in a lung cancer model Cancer Research. 74: 4242-4242. DOI: 10.1158/1538-7445.Am2014-4242 |
0.337 |
|
| 2014 |
Mehrazin R, Canter D, Egleston B, Parker D, Piotrowski Z, Tomaszewski JJ, Smaldone MC, Bloch P, Iffrig K, Abbosh P, Ito T, Viterbo R, Greenberg RE, Chen DYT, Uzzo RG, et al. Mp22-15 Neutrophil-To-Lymphocyte Ratio (Nlr): Prognostic Indicator For Overall Survival (Os) In Patients Undergoing Radical Cystectomy (Rc) The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.863 |
0.31 |
|
| 2014 |
Tomaszewski JJ, Uzzo RG, Egleston BL, Handorf E, Mehrazin R, Smaldone MC, Kutikov A. T1a Patients with Metastatic Renal Cell Cancer at Diagnosis Markedly Differ from Patients who Present with Localized Malignant Small Renal Mass (SRM) Journal of the American College of Surgeons. 219. DOI: 10.1016/J.Jamcollsurg.2014.07.361 |
0.33 |
|
| 2014 |
Bradbury AR, Patrick-Miller L, Egleston B, Schwartz L, Tuchman L, Moore CW, Rauch P, Daly M. Perceptions of Breast Cancer Risk, Psychological Adjustment and Behaviors in Adolescent Girls at High-risk and Population-risk for Breast Cancer Journal of Adolescent Health. 54. DOI: 10.1016/J.Jadohealth.2013.10.186 |
0.304 |
|
| 2013 |
Wong YN, Egleston BL, Sachdeva K, Eghan N, Pirollo M, Stump TK, Beck JR, Armstrong K, Schwartz JS, Meropol NJ. Cancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting. Medical Care. 51: 838-45. PMID 23872905 DOI: 10.1097/Mlr.0B013E31829Faffd |
0.317 |
|
| 2013 |
Giordano A, Egleston BL, Hajage D, Bland J, Hortobagyi GN, Reuben JM, Pierga JY, Cristofanilli M, Bidard FC. Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1596-602. PMID 23340302 DOI: 10.1158/1078-0432.Ccr-12-3137 |
0.35 |
|
| 2013 |
Meropol NJ, Egleston BL, Buzaglo JS, Balshem A, Benson AB, Cegala DJ, Cohen RB, Collins M, Diefenbach MA, Miller SM, Fleisher L, Millard JL, Ross EA, Schulman KA, Silver A, et al. A Web-based communication aid for patients with cancer: the CONNECT Study. Cancer. 119: 1437-45. PMID 23335150 DOI: 10.1002/Cncr.27874 |
0.319 |
|
| 2013 |
Crivello ML, Ruth K, Sigurdson ER, Egleston BL, Evers K, Wong YN, Boraas M, Bleicher RJ. Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population. Annals of Surgical Oncology. 20: 102-10. PMID 22878617 DOI: 10.1245/S10434-012-2571-4 |
0.309 |
|
| 2013 |
Miller SM, Hudson SV, Egleston BL, Manne S, Buzaglo JS, Devarajan K, Fleisher L, Millard J, Solarino N, Trinastic J, Meropol NJ. The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial Psycho-Oncology. 22: 481-489. PMID 22331643 DOI: 10.1002/Pon.3043 |
0.31 |
|
| 2013 |
Canter D, Egleston B, Wong YN, Smaldone MC, Simhan J, Greenberg RE, Uzzo RG, Kutikov A. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis. Urologic Oncology. 31: 866-70. PMID 21906968 DOI: 10.1016/J.Urolonc.2011.07.009 |
0.385 |
|
| 2013 |
Bradbury AR, Patrick-Miller LJ, Egleston B, Smith K, Fetzer D, Forman A, Bealin L, Rybak C, Rainey K, Cherry C, Montgomery S, Daly MB. A randomized trial of telephone versus in-person disclosure of BRCA 1/2 results. Journal of Clinical Oncology. 31: 1538-1538. DOI: 10.1200/Jco.2013.31.15_Suppl.1538 |
0.313 |
|
| 2013 |
Canter D, Mallin K, Egleston B, Simhan J, Smaldone MC, Canter RJ, Crispen PL, Bratslavsky G, Uzzo RG, Kutikov A. 47 The Metastatic Potential Of Retroperitoneal Tumors: Analysis And Comparison Of Renal Cell Carcinoma (Rcc), Adrenocortical Carcinoma (Acc), And Retroperitoneal Sarcoma (Rps) Cohorts From The National Cancer Data Base (Ncdb) The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1423 |
0.312 |
|
| 2012 |
Bleicher RJ, Ruth K, Sigurdson ER, Ross E, Wong YN, Patel SA, Boraas M, Topham NS, Egleston BL. Preoperative delays in the US Medicare population with breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 4485-92. PMID 23169513 DOI: 10.1200/Jco.2012.41.7972 |
0.338 |
|
| 2012 |
Smaldone MC, Egleston B, Uzzo RG, Kutikov A. Does partial nephrectomy result in a durable overall survival benefit in the Medicare population The Journal of Urology. 188: 2089-2094. PMID 23083877 DOI: 10.1016/J.Juro.2012.07.099 |
0.316 |
|
| 2012 |
Bradbury AR, Patrick-Miller L, Egleston BL, Schwartz LA, Sands CB, Shorter R, Moore CW, Tuchman L, Rauch P, Malhotra S, Rowan B, Van Decker S, Schmidheiser H, Bealin L, Sicilia P, et al. Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls. Breast Cancer Research and Treatment. 136: 749-57. PMID 23065030 DOI: 10.1007/S10549-012-2254-7 |
0.322 |
|
| 2012 |
Doss M, Egleston BL, Litwin S. Comments on "Studies of the mortality of atomic bomb survivors, report 14, 1950-2003: an overview of cancer and noncancer diseases" (Radiat Res 2012; 177:229-43). Radiation Research. 178: 244-5. PMID 22817395 DOI: 10.1667/Rr3039.1 |
0.309 |
|
| 2012 |
Smaldone MC, Kutikov A, Egleston B, Simhan J, Canter DJ, Teper E, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology. 80: 286-91. PMID 22704174 DOI: 10.1016/J.Urology.2012.02.067 |
0.311 |
|
| 2012 |
Van Cleave JH, Egleston BL, Bourbonniere M, Cardone L, McCorkle R. Functional status in older women following gynecological cancer surgery: can choice of measure influence evidence for clinical practice? Geriatric Nursing (New York, N.Y.). 33: 118-26. PMID 22387192 DOI: 10.1016/J.Gerinurse.2012.01.004 |
0.308 |
|
| 2012 |
Kutikov A, Smaldone MC, Egleston BL, Uzzo RG. Should partial nephrectomy be offered to all patients whenever technically feasible? European Urology. 61: 732-4; discussion 73. PMID 22197441 DOI: 10.1016/J.Eururo.2011.12.014 |
0.364 |
|
| 2012 |
Bleicher RJ, Ruth K, Sigurdson ER, Evers K, Crivello ML, Wong Y, Boraas M, Egleston B. Disparities in preoperative imaging for breast cancer: Not so black and white. Journal of Clinical Oncology. 30: 6061-6061. DOI: 10.1200/Jco.2012.30.15_Suppl.6061 |
0.316 |
|
| 2012 |
Bradbury A, Patrick-Miller L, Egleston B, Schwartz L, Tuchman L, Moore C, Rauch P, Sands C, Shorter R, Rowan B, Malhotra S, Decker Sv, Schmidheiser H, Sicilia P, Bealin L, et al. Abstract P6-08-01: Perceptions of breast cancer risk, psychological adjustment and behaviors in adolescent girls at high-risk and population-risk for breast cancer Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P6-08-01 |
0.306 |
|
| 2012 |
Giordano A, Reuben J, Egleston B, Hajage D, Hortobagyi G, Cristofanilli M, Pierga J, Bidard F. Abstract P2-01-01: Establishment and validation of circulating tumor cell-based prognostic nomograms in 497 first-line metastatic breast cancer patients Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-01-01 |
0.347 |
|
| 2011 |
Van Cleave JH, Egleston BL, Bourbonniere M, McCorkle R. Combining extant datasets with differing outcome measures across studies of older adults after cancer surgery. Research in Gerontological Nursing. 4: 36-46. PMID 21210576 DOI: 10.3928/19404921-20101201-02 |
0.311 |
|
| 2011 |
Bleicher R, Ruth K, Sigurdson E, Evers K, Wong Y, Boraas M, Egleston B. P5-12-05: (In-)Efficiencies in the Preoperative Imaging Evaluation of the Medicare Breast Cancer Patient. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P5-12-05 |
0.315 |
|
| 2010 |
Hall MJ, Egleston B, Miller SM, Buzaglo JS, Millard J, Ridgway C, Damjanov N, Sprandio JD, Meropol NJ. Barriers to participation in cancer prevention clinical trials. Acta Oncologica (Stockholm, Sweden). 49: 757-66. PMID 20515420 DOI: 10.3109/0284186X.2010.485209 |
0.32 |
|
| 2010 |
Wong YN, Hamilton O, Egleston B, Salador K, Murphy C, Meropol NJ. Understanding How Out-of-Pocket Expenses, Treatment Value, and Patient Characteristics Influence Treatment Choices Oncologist. 15: 566-576. PMID 20495218 DOI: 10.1634/Theoncologist.2009-0307 |
0.351 |
|
| 2010 |
Kutikov A, Uzzo RG, Caraway A, Reese CT, Egleston BL, Chen DY, Viterbo R, Greenberg RE, Wong YN, Raman JD, Boorjian SA. Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy. Bju International. 106: 218-23. PMID 19922542 DOI: 10.1111/J.1464-410X.2009.09079.X |
0.327 |
|
| 2010 |
Wang C, Miller SM, Egleston BL, Hay JL, Weinberg DS. Beliefs about the causes of breast and colorectal cancer among women in the general population. Cancer Causes & Control : Ccc. 21: 99-107. PMID 19787437 DOI: 10.1007/S10552-009-9439-3 |
0.303 |
|
| 2010 |
Lango MN, Egleston B, Ende K, Feigenberg S, D'Ambrosio DJ, Cohen RB, Ahmad S, Nicolaou N, Ridge JA. Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation Head and Neck. 32: 341-347. PMID 19693946 DOI: 10.1002/Hed.21188 |
0.317 |
|
| 2010 |
Scott WJ, Aggarwal C, Lebenthal A, Egleston B, Borghaei H, Mehra R, Somaiah N, Turaka A, Simon GR. Influence of surgical interventions on survival in patients with stage IIIb non-small cell lung cancer (NSCLC): The Fox Chase Cancer Center (FCCC) experience. Journal of Clinical Oncology. 28: 7067-7067. DOI: 10.1200/Jco.2010.28.15_Suppl.7067 |
0.33 |
|
| 2010 |
Aggarwal C, Egleston B, Li L, Borghaei H, Mehra R, Somaiah N, Turaka A, Scott WJ, Langer CJ, Simon GR. Role of surgery in patients with stage IIIA non-small cell lung cancer (NSCLC): Lessons learned from a tertiary referral cancer center experience. Journal of Clinical Oncology. 28: 7066-7066. DOI: 10.1200/Jco.2010.28.15_Suppl.7066 |
0.331 |
|
| 2010 |
Siripurapu V, Ruth K, Cristofanilli M, Egleston B, Sigurdson E, Freedman G, Goldstein L, Bleicher R. Abstract P1-14-05: Predicting Brain Metastasis in Breast Cancer Patients: Who Is at Highest Risk? Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P1-14-05 |
0.344 |
|
| 2009 |
Vig HS, Armstrong J, Egleston BL, Mazar C, Toscano M, Bradbury AR, Daly MB, Meropol NJ. Cancer genetic risk assessment and referral patterns in primary care. Genetic Testing and Molecular Biomarkers. 13: 735-41. PMID 20001580 DOI: 10.1089/Gtmb.2009.0037 |
0.313 |
|
| 2009 |
Egleston BL, Meireles SI, Flieder DB, Clapper ML. Population-based trends in lung cancer incidence in women. Seminars in Oncology. 36: 506-15. PMID 19995642 DOI: 10.1053/J.Seminoncol.2009.09.003 |
0.315 |
|
| 2009 |
Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of cancer surgery: implications for patient access to optimal care. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4671-8. PMID 19720926 DOI: 10.1200/Jco.2008.20.1715 |
0.352 |
|
| 2009 |
Burtness B, Gibson M, Egleston B, Mehra R, Thomas L, Sipples R, Quintanilla M, Lacy J, Watkins S, Murren JR, Forastiere AA. Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 20: 1242-8. PMID 19429872 DOI: 10.1093/Annonc/Mdn787 |
0.327 |
|
| 2009 |
Egleston BL, Wong YN. Sensitivity analysis to investigate the impact of a missing covariate on survival analyses using cancer registry data. Statistics in Medicine. 28: 1498-511. PMID 19235263 DOI: 10.1002/Sim.3557 |
0.389 |
|
| 2009 |
Coups EJ, Park BJ, Feinstein MB, Steingart RM, Egleston BL, Wilson DJ, Ostroff JS. Physical activity among lung cancer survivors: changes across the cancer trajectory and associations with quality of life. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 664-72. PMID 19190151 DOI: 10.1158/1055-9965.Epi-08-0589 |
0.301 |
|
| 2009 |
Scoll BJ, Wong YN, Egleston BL, Kunkle DA, Saad IR, Uzzo RG. Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis. The Journal of Urology. 181: 506-11. PMID 19084868 DOI: 10.1016/J.Juro.2008.10.026 |
0.313 |
|
| 2009 |
Rothman J, Egleston B, Wong YN, Iffrig K, Lebovitch S, Uzzo RG. Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. The Journal of Urology. 181: 29-33; discussion 33. PMID 19012902 DOI: 10.1016/J.Juro.2008.09.009 |
0.304 |
|
| 2009 |
Egleston BL, Scharfstein DO, MacKenzie E. On estimation of the survivor average causal effect in observational studies when important confounders are missing due to death. Biometrics. 65: 497-504. PMID 18759833 DOI: 10.1111/J.1541-0420.2008.01111.X |
0.564 |
|
| 2009 |
Bradbury A, Patrick-Miller L, Li T, Egleston B, Sands C, Schmidheiser H, Hlubocky F, Olopade O, Daly M, Daugherty C. Should Minors Be Offered BRCA1/2 Testing for Hereditary Breast Cancer? Opinions of Parents Who Have Undergone BRCA1/2 Testing. Cancer Research. 69: 4071-4071. DOI: 10.1158/0008-5472.Sabcs-09-4071 |
0.304 |
|
| 2009 |
Kutikov A, Uzzo RG, Egleston BL, Blakely SA, Iffrig K, Chen DYT, Viterbo R, Greenberg RE, Wong Y, Boorjian SA. Rapid Disease Progression Is The Primary Reason Patients Fail To Receive Systemic Therapy Following Cytoreductive Nephrectomy (Cn) The Journal of Urology. 181: 497-497. DOI: 10.1016/S0022-5347(09)61404-X |
0.323 |
|
| 2008 |
Mackenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Egleston BL, Salkever DS, Frey KP, Scharfstein DO. The impact of trauma-center care on functional outcomes following major lower-limb trauma. The Journal of Bone and Joint Surgery. American Volume. 90: 101-9. PMID 18171963 DOI: 10.2106/Jbjs.F.01225 |
0.576 |
|
| 2008 |
Wang C, Miller S, Egleston B, Weinberg D. Abstract B27: Beliefs about the causes of breast and colorectal cancer among women in the general population Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B27 |
0.339 |
|
| 2008 |
Kaplan DJ, Kunkle DA, Saad IR, Egleston BL, Uzzo RG. Kidney Cancer And Competing Causes Of Mortality: An Age-Based Population Study The Journal of Urology. 179: 168-168. DOI: 10.1016/S0022-5347(08)60486-3 |
0.356 |
|
| 2008 |
Pahlajani NH, Egleston BL, Buyyounouski MK, Chen DYT, Horwitz E, Pollack A. Estimating Gains in Biochemical Outcome from Various Durations of Androgen Deprivation in Patients Treated with Dose Escalated Radiotherapy for Prostate Cancer using Two Nomograms International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.888 |
0.303 |
|
| 2007 |
Mackenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, Egleston BL, Salkever DS, Weir S, Scharfstein DO. The National Study on Costs and Outcomes of Trauma. The Journal of Trauma. 63: S54-67; discussion S. PMID 18091213 DOI: 10.1097/Ta.0B013E31815Acb09 |
0.534 |
|
| 2007 |
Narra K, Mullins SR, Lee HO, Strzemkowski-Brun B, Magalong K, Christiansen VJ, McKee PA, Egleston B, Cohen SJ, Weiner LM, Meropol NJ, Cheng JD. Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer. Cancer Biology & Therapy. 6: 1691-9. PMID 18032930 DOI: 10.4161/Cbt.6.11.4874 |
0.354 |
|
| 2007 |
Egleston BL, Scharfstein DO, Freeman EE, West SK. Causal inference for non-mortality outcomes in the presence of death. Biostatistics (Oxford, England). 8: 526-45. PMID 16980696 DOI: 10.1093/Biostatistics/Kxl027 |
0.563 |
|
| 2006 |
Nathens AB, Rivara FP, MacKenzie EJ, Maier RV, Wang J, Egleston B, Scharfstein DO, Jurkovich GJ. The impact of an intensivist-model ICU on trauma-related mortality. Annals of Surgery. 244: 545-54. PMID 16998363 DOI: 10.1097/01.Sla.0000239005.26353.49 |
0.508 |
|
| 2006 |
MacKenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, Egleston BL, Salkever DS, Scharfstein DO. A national evaluation of the effect of trauma-center care on mortality. The New England Journal of Medicine. 354: 366-78. PMID 16436768 DOI: 10.1056/Nejmsa052049 |
0.529 |
|
| Show low-probability matches. |